Related content

Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma

By Hirakawa Tsuneaki   Yamaguchi Hiroki   Yokose Norio   Gomi Seiji   Inokuchi Koiti   Dan Kazuo  

Annals of Hematology, Vol. 89, Iss. 9, 2010-09 ,pp. : 897-904

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung

By Aviles Agustin   Nambo Maria J.   Huerta-Guzman Judith   Silva Luis   Neri Natividad  

Hematology, Vol. 18, Iss. 2, 2013-03 ,pp. : 81-84

Maney Publishing

Access to resources Recommend Favorite

Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population

By Yang Shen  

Annals of Hematology, Vol. 88, Iss. 9, 2009-09 ,pp. : 863-869

Springer Publishing Company

Access to resources Recommend Favorite

Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP

By Lin Peng-Chan   Hsiao Liang-Tsai   Poh Say-Bee   Wang Wei-Shu   Yen Chueh-Chuan   Chao Ta-Chung   Liu Jin-Hwang   Chiou Tzeon-Jye   Chen Po-Min  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 95-100

Springer Publishing Company

Access to resources Recommend Favorite

Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy

By Takács István  

Annals of Hematology, Vol. 83, Iss. 9, 2004-09 ,pp. : 608-610

Springer Publishing Company

Access to resources Recommend Favorite